In the current study, solasonine treatment significantly suppressed Bcl‐2 protein expression in SGC‐7901 cells, which was consistent with previous findings in HCC HepG2 cells and prostate cancer PC‐3 cells.30, 31. The gene discussed is BCL2; the disease is prostate carcinoma.